Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 AUD | 0.00% | -9.09% | 0.00% |
Mar. 08 | Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform | MT |
Feb. 28 | Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daya Uka
DFI | Director of Finance/CFO | - | 15-12-31 |
James Mckenna
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-18 |
Chief Operating Officer | - | 21-12-12 | |
Leah Pieris
SEC | Corporate Secretary | - | Jan. 16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Hainsworth
CHM | Chairman | 50 | 22-10-30 |
Bradley Dilkes
BRD | Director/Board Member | 39 | 22-10-30 |
Bradley Latham
BRD | Director/Board Member | 62 | 23-07-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,686,239,419 | 1,001,476,080 ( 59.39 %) | 0 | 59.39 % |
Company contact information
Algorae Pharmaceuticals Ltd.
23 Edwin Street Unit 107
1024, Mount Eden
+61 2 9698 5414
http://www.lctglobal.comSector
1st Jan change | Capi. | |
---|---|---|
0.00% | 11M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 1AI Stock
- Company Algorae Pharmaceuticals Limited